MTOR and fungal infectious disease: A 2023 review by Silva et al. (18) highlighted the role of ISA in treating invasive fungal infections in solid organ transplant recipients, emphasizing the importance of adjusting tacrolimus and mTOR inhibitor dosages during treatment to mitigate drug interactions.